申请人:Celltech Therapeutics Limited
公开号:US06329372B1
公开(公告)日:2001-12-11
Phenylalanine derivatives of formula (1) are described:
wherein
R is a carboxylic acid or a derivative thereof;
L1 is a linker atom or group;
Het is an optionally substituted heteroaromatic group;
and the salts, solvates, hydrates and N-oxides thereof.
The compounds are able to inhibit the binding of alpha4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
描述了式(1)的苯丙氨酸衍生物:其中R为羧酸或其衍生物;L1为连接原子或基团;Het为可选择取代的杂芳基团;以及它们的盐、溶剂合物、水合物和N-氧化物。这些化合物能够抑制α4整合素与其配体的结合,并可用于预防和治疗免疫或炎症性疾病。